Principal Display Panel (25 mg Bottle Label)
Orphenadrine Citrate Aspirin Caffeine
Product Images NDC 50564-555
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate Aspirin Caffeine (NDC 50564-555). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Jerome Stevens Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (50 mg Bottle Label)
This is a description of a medication named "Orphenadrine Citrate, Aspirin, Caffeine Forte" available in a container with 100 tablets. The text includes instructions for pharmacists to dispense it in a light container. The medication's NDC number is 50664-555-01. It also includes a cautionary advisory to store the medication below 30°C (86°F). The rest of the text is not legible and appears to be faulty output.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
